5 OPERATING EXPENDITURES For the year ended 30 June 2023 $ For the year ended 30 June 2022 $ General and Administration Employee Expenditure - Staff wages and superannuation 1,320,309 1,143,194 - Directors’ fees 221,000 254,786 - Contractor fees 1,920 15,568 - Other employment expenses 371,284 356,699 1,914,513 1,770,247 Administrative Costs - Consulting and legal fees 2,147,043 1,514,422 - Legal settlement payment 1,000,000 – - Loss on deconsolidation of BARD1AG 124,764 – - Transfer to the income statement of FCTR component related to BARD1AG 213,035 – - ASX listing and transaction fees plus share registry fees 132,421 213,426 - Lease liability interest 59,524 81,963 - Other administration expenses 88,092 381,060 3,764,879 2,190,871 Depreciation and amortisation - Amortisation of acquired intangible asset - hTERT 54,790 389,066 - Amortisation of acquired intangible asset - Molecular Nets 890,144 1,288,342 - Amortisation of granted patents 20,030 34,354 - Depreciation of building improvements 24,102 24,102 - Depreciation of right-of-use assets – AASB 16 Leases 137,499 137,499 - Depreciation of plant and equipment 26,944 20,622 1,153,509 1,893,985 Per consolidated Statement of Comprehensive Income 6,832,901 5,855,103 49 Annual Report 2023
RkJQdWJsaXNoZXIy MjE2NDg3